Insights

Insights

Filter by:
Governing Laws
Sector
Sub-sector
Service
Sub-service
Hot Topics
Life sciences & healthcare

Biologics and biosimilars litigation update

25 November 2020
Quick read

by multiple authors

Click here to find out more
Life sciences & healthcare

Biologics and biosimilars litigation update

7 August 2020
QUICK READ

by Matthew Royle, Ph.D.

Click here to find out more
Life sciences & healthcare

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

27 July 2020
QUICK READ

by multiple authors

Click here to find out more
Life sciences & healthcare

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 April 2020

by multiple authors

Click here to find out more
Life sciences & healthcare

Biosimilars – The economics of biosimilars: Market access, pricing and legal considerations

17 December 2019

by Matthew Royle, Ph.D.

Click here to find out more
Life sciences & healthcare

Biosimilars – Clearing the way for launch

30 September 2019
QUICK READ

by multiple authors

Click here to find out more
Life sciences & healthcare

Synapse - September 2019

27 September 2019

by multiple authors

Click here to find out more
Life sciences & healthcare

Biosimilars - clearing the way for launch

22 September 2019

by multiple authors

Click here to find out more
Life sciences & healthcare

Webinar: Recent legislative developments affecting biologics and biosimilars

30 June 2019
Quick read

by multiple authors

Click here to find out more
Life sciences & healthcare

Recent legislative developments affecting biologics and biosimilars

30 May 2019

by multiple authors

Click here to find out more
Life sciences & healthcare

Biosimilars webinar series – Recent developments in biosimilars settlements, market landscape and antitrust scrutiny

29 March 2019
Quick read

by multiple authors

Click here to find out more
Overhead view of scientist using centrifuge machine
Patents & innovation

Synapse

March 2019

25 March 2019

by multiple authors

Click here to find out more